| CAS ID: | 81-81-2 |
| Molecular Formula: | C19H16O4 |
| Molecular Weight: | 308.3 g/mol |
| Monoisotopic Mass: | 308.1049 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ATHROMBIN | WARFARIN POTASSIUM | COUMADIN | PANWARFIN | WARFARIN | ATHROMBIN-K | MAREVAN | JANTOVEN | WARFARIN SODIUM |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT00180674 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 16, 2005 | Last Verified | November 11, 2016 |
| Sponsor | Imperial College London | ||
Trial Record 2
| ClinicalTrial ID | NCT00957242 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 3 | Status | Terminated |
| First Received | August 12, 2009 | Last Verified | July 23, 2014 |
| Sponsor | Duke University | ||
Trial Record 3
| ClinicalTrial ID | NCT02526303 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | August 18, 2015 | Last Verified | February 15, 2017 |
| Sponsor | Fourth Military Medical University | ||
Trial Record 4
| ClinicalTrial ID | NCT02247414 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | September 25, 2014 | Last Verified | November 6, 2017 |
| Sponsor | Yangzhou University | ||
Trial Record 5
| ClinicalTrial ID | NCT02238444 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Recruiting |
| First Received | September 12, 2014 | Last Verified | January 1, 2019 |
| Sponsor | Yangzhou University | ||
| PubChem: | 54678486 |
| ChEMBL: | CHEMBL1464 |